CSIMarket
 


Atara Biotherapeutics Inc   (ATRA)
Other Ticker:  
 
 

ATRA's Free Cash Flow Growth by Quarter and Year

Atara Biotherapeutics Inc 's Free Cash Flow results by quarter and year




ATRA Free Cash Flow (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - -56.88 -34.27 -52.96
III Quarter September -51.35 -65.06 -58.98 -56.64
II Quarter June -52.80 -63.96 -61.58 -67.04
I Quarter March -38.43 -84.53 -65.70 -58.69
FY   -142.58 -270.43 -220.53 -235.33



ATRA Free Cash Flow third quarter 2023 Y/Y Growth Comment
Atara Biotherapeutics Inc in the third quarter 2023 recorded free cash outflow of $ -51.35 millions.

According to the results reported in the third quarter 2023, Atara Biotherapeutics Inc achieved the best Free Cash Flow growth in Biotechnology & Pharmaceuticals industry. While Atara Biotherapeutics Inc ' s Free Cash Flow no change of % ranks overall at the positon no. in the third quarter 2023.




ATRA Free Cash Flow ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Atara Biotherapeutics Inc 's third quarter 2023 Free Cash Flow $ -51.35 millions ATRA's Income Statement
Atara Biotherapeutics Inc 's third quarter 2022 Free Cash Flow $ -65.06 millions Quarterly ATRA's Income Statement
New: More ATRA's historic Free Cash Flow Growth >>


ATRA Free Cash Flow (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Free Cash Flow third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Free Cash Flow third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Free Cash Flow by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Atara Biotherapeutics Inc 's Q/Q Free Cash Flow Growth


Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ATRA's III. Quarter Q/Q Free Cash Flow Comment
Even if Atara Biotherapeutics Inc in the III. Quarter 2023 showed free cash outflow of $ -51.35 millions, management said, that this are slight up side in contrast to the -52.80 millions in the second quarter.

Within Biotechnology & Pharmaceuticals industry Atara Biotherapeutics Inc achieved highest sequential Free Cash Flow growth. While Atara Biotherapeutics Inc 's Free Cash Flow growth quarter on quarter, overall rank is .


Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ATRA's III. Quarter Q/Q Free Cash Flow Comment
Although Atara Biotherapeutics Inc in the III. Quarter 2023 admitted free cash outflow of $ -51.35 millions, it should be mentioned, that this show recovery compare to the -52.80 millions in the second quarter.

Within Biotechnology & Pharmaceuticals industry Atara Biotherapeutics Inc achieved highest sequential Free Cash Flow growth. While Atara Biotherapeutics Inc 's Free Cash Flow growth quarter on quarter, overall rank is .


Atara Biotherapeutics Inc 's 12 Months Free Cash Flow Growth Year on Year


Free Cash Flow TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Free Cash Flow 12 Months Ending $ -198.24 $ -212.10 $ -222.34 $ -266.24 $ -241.20
Y / Y Free Cash Flow Growth (TTM) - - - - -
Year on Year Free Cash Flow Growth Overall Ranking # # # # #
Seqeuential Free Cash Flow Change (TTM) - - - - -
Seq. Free Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Free Cash Flow growth Comment


Atara Biotherapeutics Inc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Free Cash Flow growth Comment


Atara Biotherapeutics Inc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Free Cash Flow Growth
Biotechnology & Pharmaceuticals Industry Free Cash Flow Growth Trends and Statistics
Healthcare Sector Free Cash Flow Growth Statistics
Free Cash Flow Growth Trends for overall market
ATRA's Free Cash Flow Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Growth
Lowest Ranking Free Cash Flow Growth
Free Cash Flow Growth for ATRA's Competitors
Free Cash Flow Growth for Atara Biotherapeutics Inc 's Suppliers
Free Cash Flow Growth for ATRA's Customers

You may also want to know
ATRA's Annual Growth Rates ATRA's Profitability Ratios ATRA's Asset Turnover Ratio ATRA's Dividend Growth
ATRA's Roe ATRA's Valuation Ratios ATRA's Financial Strength Ratios ATRA's Dividend Payout Ratio
ATRA's Roa ATRA's Inventory Turnover Ratio ATRA's Growth Rates ATRA's Dividend Comparisons



Companies with similar Free Cash Flow no change for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Free Cash Flow for the quarter ending Sep 30 2023
Abbvie inc -0.37%$ -0.368 millions
Insulet Corporation-1.23%$ -1.235 millions
National Research Corporation-2.32%$ -2.318 millions
Fonar Corporation-2.93%$ -2.929 millions
Viatris Inc -4.02%$ -4.016 millions
Pediatrix Medical Group Inc -4.07%$ -4.071 millions
Repligen Corp-5.16%$ -5.164 millions
Davita Inc -6.95%$ -6.948 millions
Amgen Inc -7.32%$ -7.320 millions
Adapthealth Corp -7.65%$ -7.653 millions
Dexcom Inc -8.19%$ -8.186 millions
Biogen Inc -10.38%$ -10.378 millions
Avantor Inc -10.69%$ -10.685 millions
Amneal Pharmaceuticals Inc -13.02%$ -13.020 millions
Biomarin Pharmaceutical Inc-14.32%$ -14.322 millions
Organon and Co -17.67%$ -17.666 millions
Hca Healthcare Inc -17.91%$ -17.914 millions
Zimmer Biomet Holdings Inc -25.11%$ -25.111 millions
International Stem Cell Corporation-26.19%$ -26.190 millions
Jazz Pharmaceuticals Plc-26.51%$ -26.507 millions
Universal Health Services Inc -26.74%$ -26.740 millions
Brookdale Senior Living Inc -27.96%$ -27.956 millions
Pacific Health Care Organization Inc -29.00%$ -29.004 millions
Option Care Health Inc -29.95%$ -29.952 millions
Iqvia Holdings Inc -32.44%$ -32.445 millions
Abbott Laboratories-32.48%$ -32.482 millions
Bruker Corporation-36.55%$ -36.547 millions
Sotera Health Company-38.26%$ -38.257 millions
Puma Biotechnology Inc -38.50%$ -38.496 millions
Luna Innovations Inc-38.51%$ -38.514 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com